
Majuven
Asia, Central Region, Singapore, Singapore'/%3e%3cuse xlink:href='%23a' transform='translate(288.889 -214.211)'/%3e%3cuse xlink:href='%23a' transform='translate(108 342.749)'/%3e%3cuse xlink:href='%23a' transform='translate(469.189 342.749)'/%3e%3c/svg%3e)
Description
Majuven is an early and growth stage VC fund founded by experienced business leaders in Singapore in 2012.
Investor Profile
Majuven has backed more than 6 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 4 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series C, Series A, Series B rounds (top funding stages).
- Majority of deals are located in United States, Singapore, China.
- Strong thematic focus on Biotechnology, Health Care, Medical.
Stage Focus
- Series C (33%)
- Series A (33%)
- Series B (17%)
- Series Unknown (17%)
Country Focus
- United States (50%)
- Singapore (17%)
- China (17%)
- Taiwan (17%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- B2b
- Cloud Computing
- Enterprise Software
- Fintech
- Lending
- Saas
- Software
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.